27 research outputs found
Maintenance Bacillus Calmette-Guerin for Ta, T1 bladder cancer is not associated with increased toxicity. Results from an European organization for research and treatment of cancer genitourinary group phase III trial.
The side effects of bacillus calmette-guerin in the treatment of TA Ti bladder cancer do not predict its efficacy: Results from an eortic genito-urinary group phase III trial
Maintenance bacillus calmette-guerin for TA, T1 bladder cancer is not associated with increased toxicity, results from an eortc genito-urinary group phase III trial
Maintenance bacillus Calmette-Guerin for TaT1 bladder tumors is not associated with increased toxicity: results from a European organisation for research and treatment of cancer genito-urinary group phase III trial.
C